Overview

To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The study aims to evaluate if blood levels of desipramine change whilst being dosed at the same time with daily mirabegron.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Desipramine
Mirabegron